Compare SNGX & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNGX | CTNT |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 4.9M |
| IPO Year | 2006 | 2023 |
| Metric | SNGX | CTNT |
|---|---|---|
| Price | $0.39 | $1.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 903.1K | ★ 1.3M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.03 | ★ 57.74 |
| EPS | ★ N/A | N/A |
| Revenue | $119,371.00 | ★ $1,288,536.00 |
| Revenue This Year | N/A | $42.49 |
| Revenue Next Year | N/A | $22.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 182.69 |
| 52 Week Low | $0.28 | $0.02 |
| 52 Week High | $6.23 | $4.21 |
| Indicator | SNGX | CTNT |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 51.33 |
| Support Level | $0.37 | $1.53 |
| Resistance Level | $0.41 | $2.01 |
| Average True Range (ATR) | 0.02 | 0.22 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 21.25 | 32.20 |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.